Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
Titel:
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
Auteur:
Garber, Alan J King, Allen B Prato, Stefano Del Sreenan, Seamus Balci, Mustafa K Muñoz-Torres, Manuel Rosenstock, Julio Endahl, Lars A Francisco, Ann Marie Ocampo Hollander, Priscilla